Relationship between Toxoplasma gondii infection and psychiatric disorders in Iran: A systematic review with meta-analysis

被引:2
作者
Montazeri, Mahbobeh [1 ]
Moradi, Elahe [1 ,2 ]
Moosazadeh, Mahmood [3 ]
Hosseini, Seyed Hamzeh [1 ,4 ]
Fakhar, Mahdi [5 ]
机构
[1] Mazandaran Univ Med Sci, Communicable Dis Inst, Toxoplasmosis Res Ctr, Sari, Iran
[2] Mazandaran Univ Med Sci, Student Res Comm, Sari, Iran
[3] Mazandaran Univ Med Sci, Noncommunicable Dis Inst, Gastrointestinal Canc Res Ctr, Sari, Iran
[4] Mazandaran Univ Med Sci, Psychiat & Behav Sci Res Ctr, Sari, Iran
[5] Mazandaran Univ Med Sci, Imam Khomeini Hosp, Iranian Natl Registry Ctr Toxoplasmosis INRCT, Sari, Iran
关键词
MENTALLY-RETARDED PATIENTS; RISK-FACTORS; SCHIZOPHRENIA-PATIENTS; BIPOLAR DISORDER; BLOOD-DONORS; ANTIBODIES; SEROPREVALENCE; CHILDREN; ASSAY; SEROPOSITIVITY;
D O I
10.1371/journal.pone.0284954
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundToxoplasma gondii, a ubiquitous parasitic protozoan, may be an important cause of neurological and psychiatric diseases. The present systematic review and meta-analysis, therefore, was conducted to investigate the scientific evidence regarding the potential association between T. gondii infection and psychiatric disorders in Iran. MethodsWe systematically reviewed articles from world-wide databases, including PubMed, Scopus, Science Direct, Web of Science, Google Scholar, and Iranian national databases up to July 30(th), 2021. The Newcastle Ottawa Scale (NOS) was used to assess the quality of included studies. The common odds ratio (OR) was estimated using inverse variance and a random-effects model. Heterogeneity was assessed using the & chi;2-based Cochrane test (Q) and the I-2 index. Also, sensitivity analyses and publication bias were calculated. Moreover, subgroup analysis was performed based on the type of disorder and quality score of different eligible studies. Results16 studies were included in this meta-analysis. Our meta-analyses found that the OR of the risk of anti- T. gondii IgG and IgM in psychiatric patients compared to the control group was 1.56 (95% CI; 1.23-1.99) and 1.76 (95% CI: 1.19-2.61), respectively. Subgroup analysis based on the type of disorder showed that the OR of the risk of anti- T. gondii IgG in Iranian schizophrenia patients and other psychiatric disorders compared to the control group were 1.50 (95% CI; 1.09-2.07) and 2.03 (95% CI: 1.14-3.60), respectively, which are statistically significant. Also, the OR of the risk of anti- T. gondii IgM in Iranian schizophrenia and depression patients compared to the control group was 1.54 (95% CI; 0.9-2.64) and 1.03 (95% CI: 0.2-5.24), respectively, which are not statistically significant. Additionally, subgroup analysis based on quality scores showed no significant influence on the results according to the moderate quality studies. However, this association was significant according to the high quality studies. The obtained results of Egger's test were 1.5 (95% CI; -0.62-3.73, P = 0.15) and 0.47 (95% CI; -0.82-1.76, P = 0.45), respectively, indicating publication bias. The significant results of the heterogeneity analysis confirmed a high level of heterogeneity in the IgG test (P = 0.000, I-2 = 66.6%). However, no significant results from the test of heterogeneity were detected in the IgM test (P = 0.15, I-2 = 27.5%). The results of the sensitivity analysis showed that the impact of each study on the meta-analysis was not significant on overall estimates. ConclusionsDespite the limited number of studies, these outcomes supported a possible link between T. gondii infection and psychiatric disorders in Iran. However, more high-quality investigations are needed in the future.
引用
收藏
页数:17
相关论文
共 55 条
[1]  
Abdollahian E, 2017, IRAN J PARASITOL, V12, P117
[2]  
Afsharpaiman S, 2017, IRAN J CHILD NEUROL, V11, P32
[3]  
Afsharpaiman S, 2016, GALEN MED J, V5, P188
[4]  
Alipour A, 2011, IRAN J PARASITOL, V6, P31
[5]   Antibodies to infectious agents in individuals at ultra-high risk for psychosis [J].
Amminger, G. Paul ;
McGorry, Patrick D. ;
Berger, Gregor E. ;
Wade, Darryl ;
Yung, Alison R. ;
Phillips, Lisa J. ;
Harrigan, Susy M. ;
Francey, Shona M. ;
Yolken, Robert H. .
BIOLOGICAL PSYCHIATRY, 2007, 61 (10) :1215-1217
[6]  
Anoshirvani K., 2019, ANN MED HEALTH SCI R, V17
[7]   Association of Toxoplasma gondii infection with schizophrenia and its relationship with suicide attempts in these patients [J].
Ansari-Lari, Maryam ;
Farashbandi, Hassan ;
Mohammadi, Fahimeh .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 (10) :1322-1327
[8]   Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders [J].
Burgdorf, Kristoffer Solvsten ;
Trabjerg, Betina B. ;
Pedersen, Marianne Giortz ;
Nissen, Janna ;
Banasik, Karina ;
Pedersen, Ole Birger ;
Sorensen, Erik ;
Nielsen, Kaspar Rene ;
Larsen, Margit Horup ;
Erikstrup, Christian ;
Bruun-Rasmussen, Peter ;
Westergaard, David ;
Thorner, Lise Wegner ;
Hjalgrim, Henrik ;
Paarup, Helene Martina ;
Brunak, Soren ;
Pedersen, Carsten B. ;
Torrey, E. Fuller ;
Werge, Thomas ;
Mortensen, Preben Bo ;
Yolken, Robert H. ;
Ullum, Henrik .
BRAIN BEHAVIOR AND IMMUNITY, 2019, 79 :152-158
[9]   Effects of Toxoplasma gondii infection on the brain [J].
Carruthers, Vern B. ;
Suzuki, Yasuhiro .
SCHIZOPHRENIA BULLETIN, 2007, 33 (03) :745-751
[10]   Is there any association between Toxoplasma gondii infection and depression? A systematic review and meta-analysis [J].
Chegeni, Tooran Nayeri ;
Sharif, Mehdi ;
Sarvi, Shahabeddin ;
Moosazadeh, Mahmood ;
Montazeri, Mahbobeh ;
Aghayan, Sargis A. ;
Balalami, Nader Jafari ;
Gholami, Shirzad ;
Hosseininejad, Zahra ;
Saberi, Reza ;
Anvari, Davood ;
Gohardehi, Shaban ;
Daryani, Ahmad .
PLOS ONE, 2019, 14 (06)